Absorption |
Blood-Brain Barrier | BBB+ | 0.9639 |
Human Intestinal Absorption | HIA+ | 1.0000 |
Caco-2 Permeability | Caco2+ | 0.5491 |
P-glycoprotein Substrate | Non-substrate | 0.7793 |
P-glycoprotein Inhibitor | Non-inhibitor | 0.6468 |
Non-inhibitor | 0.9574 |
Renal Organic Cation Transporter | Non-inhibitor | 0.8927 |
Distribution |
Subcellular localization | Mitochondria | 0.8506 |
Metabolism |
CYP450 2C9 Substrate | Non-substrate | 0.7652 |
CYP450 2D6 Substrate | Non-substrate | 0.8021 |
CYP450 3A4 Substrate | Non-substrate | 0.5343 |
CYP450 1A2 Inhibitor | Non-inhibitor | 0.7478 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.7112 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.9262 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.6492 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.6747 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.5259 |
Excretion |
Toxicity |
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.8792 |
Non-inhibitor | 0.8906 |
AMES Toxicity | Non AMES toxic | 0.8845 |
Carcinogens | Carcinogens | 0.6852 |
Fish Toxicity | High FHMT | 0.8614 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.9061 |
Honey Bee Toxicity | High HBT | 0.9568 |
Biodegradation | Not ready biodegradable | 0.7401 |
Acute Oral Toxicity | III | 0.8172 |
Carcinogenicity (Three-class) | Non-required | 0.6171 |